Search Results - "KOGAN, Scott"

Refine Results
  1. 1
  2. 2

    A Rapid and Scalable System for Studying Gene Function in Mice Using Conditional RNA Interference by Premsrirut, Prem K., Dow, Lukas E., Kim, Sang Yong, Camiolo, Matthew, Malone, Colin D., Miething, Cornelius, Scuoppo, Claudio, Zuber, Johannes, Dickins, Ross A., Kogan, Scott C., Shroyer, Kenneth R., Sordella, Raffaella, Hannon, Gregory J., Lowe, Scott W.

    Published in Cell (01-04-2011)
    “…RNA interference is a powerful tool for studying gene function, however, the reproducible generation of RNAi transgenic mice remains a significant limitation…”
    Get full text
    Journal Article
  3. 3

    Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity by Chien, Yuchen, Scuoppo, Claudio, Wang, Xiaowo, Fang, Xueping, Balgley, Brian, Bolden, Jessica E, Premsrirut, Prem, Luo, Weijun, Chicas, Agustin, Lee, Cheng S, Kogan, Scott C, Lowe, Scott W

    Published in Genes & development (15-10-2011)
    “…Cellular senescence acts as a potent barrier to tumorigenesis and contributes to the anti-tumor activity of certain chemotherapeutic agents. Senescent cells…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice by Voisset, Edwige, Moravcsik, Eva, Stratford, Eva W., Jaye, Amie, Palgrave, Christopher J., Hills, Robert K., Salomoni, Paolo, Kogan, Scott C., Solomon, Ellen, Grimwade, David

    Published in Blood (08-02-2018)
    “…A hallmark of acute promyelocytic leukemia (APL) is altered nuclear architecture, with disruption of promyelocytic leukemia (PML) nuclear bodies (NBs) mediated…”
    Get full text
    Journal Article
  7. 7

    Crenolanib is a selective type I pan-FLT3 inhibitor by Smith, Catherine Choy, Lasater, Elisabeth A., Lin, Kimberly C., Wang, Qi, McCreery, Melissa Quino, Stewart, Whitney K., Damon, Lauren E., Perl, Alexander E., Jeschke, Grace R., Sugita, Mayumi, Carroll, Martin, Kogan, Scott C., Kuriyan, John, Shah, Neil P.

    “…Tyrosine kinase inhibitors (TKIs) represent transformative therapies for several malignancies. Two critical features necessary for maximizing TKI tolerability…”
    Get full text
    Journal Article
  8. 8

    CUL4A Induces Epithelial-Mesenchymal Transition and Promotes Cancer Metastasis by Regulating ZEB1 Expression by YUNSHAN WAN, MINGXIN WEN, LABARGE, Mark A, LIANG YOU, KOGAN, Scott C, GRAY, Joe W, MAO, Jian-Hua, GUANGWEI WEI, YONGWON KWON, YANGYANG XU, YUEYONG LIU, PENGJU ZHANG, XIUQUAN HE, QIN WANG, YURONG HUANG, JEN, Kuang-Yu

    Published in Cancer research (Chicago, Ill.) (15-01-2014)
    “…The ubiquitin ligase CUL4A has been implicated in tumorigenesis, but its contributions to progression and metastasis have not been evaluated. Here, we show…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal by Zhao, Zhen, Zuber, Johannes, Diaz-Flores, Ernesto, Lintault, Laura, Kogan, Scott C, Shannon, Kevin, Lowe, Scott W

    Published in Genes & development (01-07-2010)
    “…The p53 tumor suppressor limits proliferation in response to cellular stress through several mechanisms. Here, we test whether the recently described ability…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Preclinical efficacy of MEK inhibition in Nras-mutant AML by Burgess, Michael R., Hwang, Eugene, Firestone, Ari J., Huang, Tannie, Xu, Jin, Zuber, Johannes, Bohin, Natacha, Wen, Tiffany, Kogan, Scott C., Haigis, Kevin M., Sampath, Deepak, Lowe, Scott, Shannon, Kevin, Li, Qing

    Published in Blood (18-12-2014)
    “…Oncogenic NRAS mutations are highly prevalent in acute myeloid leukemia (AML). Genetic analysis supports the hypothesis that NRAS mutations cooperate with…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Mouse models of human AML accurately predict chemotherapy response by Zuber, Johannes, Radtke, Ina, Pardee, Timothy S, Zhao, Zhen, Rappaport, Amy R, Luo, Weijun, McCurrach, Mila E, Yang, Miao-Miao, Dolan, M Eileen, Kogan, Scott C, Downing, James R, Lowe, Scott W

    Published in Genes & development (01-04-2009)
    “…The genetic heterogeneity of cancer influences the trajectory of tumor progression and may underlie clinical variation in therapy response. To model such…”
    Get full text
    Journal Article
  18. 18

    Curing APL: Differentiation or Destruction? by Kogan, Scott C.

    Published in Cancer cell (06-01-2009)
    “…In a recent issue of Nature Medicine, Nasr et al. show that the effectiveness of all- trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia…”
    Get full text
    Journal Article
  19. 19

    In utero and early-life exposure to thirdhand smoke causes profound changes to the immune system by Snijders, Antoine M, Zhou, Mi, Whitehead, Todd P, Fitch, Briana, Pandey, Priyatama, Hechmer, Aaron, Huang, Abel, Schick, Suzaynn F, de Smith, Adam J, Olshen, Adam B, Metayer, Catherine, Mao, Jian-Hua, Wiemels, Joseph L, Kogan, Scott C

    Published in Clinical science (1979) (30-04-2021)
    “…Acute lymphoblastic leukemia (ALL) is the most common cancer in children. Thirdhand smoke (THS) is the residual tobacco contamination that remains after the…”
    Get more information
    Journal Article
  20. 20

    mTORC1 Promotes Survival through Translational Control of Mcl-1 by Mills, John R., Hippo, Yoshitaka, Robert, Francis, Chen, Samuel M. H., Malina, Abba, Lin, Chen-Ju, Trojahn, Ulrike, Wendel, Hans-Guido, Charest, Al, Bronson, Roderick T., Kogan, Scott C., Nadon, Robert, Housman, David E., Lowe, Scott W., Pelletier, Jerry

    “…Activation of the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway is a frequent occurrence in human cancers and a major promoter of chemotherapeutic…”
    Get full text
    Journal Article